Study on Topical Infliximab for Autoimmune Dry Eye Disease in Sjögren's Syndrome
A clinical trial is underway to evaluate the safety and efficacy of topical infliximab for treating severe dry eye in Sjögren's syndrome.
Asset / Drug
Drug and asset intelligence for infliximab with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.